On 21 September 2015 the French Federation for Public Physical Education (UFOLEP) Disciplinary Panel decided to impose a warning on the cyclist after he tested positive for the prohibited substance Tuaminoheptane.
Hereafter the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in his defence.
The Athlete admitted the violation and denied the intentional use of the substance. He explained with evidence that he underwent medical treatment for his virus infection and that he had used Rhinofluimucil spray (Tuaminoheptane) prescribed by his doctor.
The AFLD determines that:
- The Athlete committed an anti-doping rule violation;
- He underwent legitimate medical treatment for his condition;
- There was a medical justification for the prescribed substance;
- His use of the prescribed medication was consistent with the concentration found in his sample;
Therefore the AFLD decides on 3 February 2016 to annul the UFOLEP Decision and for the acquittal of the Athlete.
